I. Tanaka

Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor

D. Ito, K. Sawada, K. Miyazaki, 2011, International journal of molecular medicine.

Altered expression of HES-1, BETA2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells.

K. Katayama, Y. Mizui, Y. Shinozuka, 2001, Biochemical and biophysical research communications.

E6201 [(3S,4R,5Z,8S,9S,11E)-14-(Ethylamino)-8, 9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione], a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase (MEK)-1 and MEK Kinase-1: In Vitro Characterization o

F. Gusovsky, Jesse C. Chow, Y. Mizui, 2009, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of NF‐κB transcriptional activity by α‐tocopheryl succinate

Tetsuya Nakamura, I. Tanaka, A. Matsumoto, 1998 .

Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory lead.

F. Gusovsky, Y. Wang, J. Harmange, 2009, Bioorganic & medicinal chemistry letters.

Inhibition of NF-kappa B transcriptional activity by alpha-tocopheryl succinate.

T. Nakamura, I. Tanaka, A. Matsumoto, 1998, BioFactors.

INVOLVEMENT OF NF-κB p50/p65 HETERODIMER IN ACTIVATION OF THE HUMAN PRO-INTERLEUKIN-1β GENE AT TWO SUBREGIONS OF THE UPSTREAM ENHANCER ELEMENT

K. Katayama, I. Tanaka, F. Shirakawa, 1999 .

Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element.

K. Katayama, I. Tanaka, F. Shirakawa, 1999, Cytokine.

Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.

K. Katayama, I. Tanaka, K. Yamada, 1996, Molecular pharmacology.